{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:31:14Z","timestamp":1792009874624,"version":"4.4.0"},"reference-count":104,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Reviews in Medical Virology"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Human parainfluenza virus\u2010type 3 (HPIV3) is a respiratory virus responsible for mild illnesses in most of the population and severe illnesses, such as bronchiolitis and pneumonia, in young children, immunocompromised individuals and the elderly. To date, no vaccines nor antiviral drugs have been approved against HPIV3, despite its significant burden in vulnerable people. In this review, we present both past and current prophylactic strategies against HPIV3, such as live\u2010attenuated virus, vector\u2010based, subunit and mRNA vaccine candidates or antibody\u2010based passive protection. For each strategy, we give an overview of the most promising candidates evaluated in preclinical studies and we report immunogenicity and protection data from clinical trials. Finally, we discuss the most important challenges regarding those vaccine strategies and their potential administration to the different vulnerable populations.<\/jats:p>","DOI":"10.1002\/rmv.70071","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:58:49Z","timestamp":1760039929000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Landscape of Prophylactic Strategies Against Human Parainfluenza Virus Type 3"],"prefix":"10.1002","volume":"35","author":[{"given":"Cl\u00e9mence","family":"Vacher","sequence":"first","affiliation":[{"name":"CIRI Centre International de Recherche en Infectiologie Team VirPath Inserm Universit\u00e9 Claude Bernard Lyon 1 CNRS, ENS de Lyon  Lyon France"},{"name":"Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Qu\u00e9bec and Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"International Research Laboratory RESPIVIR France \u2010 Canada, Centre Hospitalier Universitaire de Qu\u00e9bec\u2010Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"Centre International de Recherche en Infectiologie Facult\u00e9 de M\u00e9decine RTH Laennec Universit\u00e9 Claude Bernard Lyon 1 Universit\u00e9 de Lyon INSERM CNRS, ENS de Lyon  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9777-2968","authenticated-orcid":false,"given":"Julia","family":"Dubois","sequence":"additional","affiliation":[{"name":"CIRI Centre International de Recherche en Infectiologie Team VirPath Inserm Universit\u00e9 Claude Bernard Lyon 1 CNRS, ENS de Lyon  Lyon France"},{"name":"International Research Laboratory RESPIVIR France \u2010 Canada, Centre Hospitalier Universitaire de Qu\u00e9bec\u2010Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"Centre International de Recherche en Infectiologie Facult\u00e9 de M\u00e9decine RTH Laennec Universit\u00e9 Claude Bernard Lyon 1 Universit\u00e9 de Lyon INSERM CNRS, ENS de Lyon  Lyon France"},{"name":"Virnext Facult\u00e9 de M\u00e9decine RTH Laennec Universit\u00e9 Claude Bernard Lyon 1  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-5097","authenticated-orcid":false,"given":"Marie\u2010Eve","family":"Hamelin","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Qu\u00e9bec and Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"International Research Laboratory RESPIVIR France \u2010 Canada, Centre Hospitalier Universitaire de Qu\u00e9bec\u2010Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"Centre International de Recherche en Infectiologie Facult\u00e9 de M\u00e9decine RTH Laennec Universit\u00e9 Claude Bernard Lyon 1 Universit\u00e9 de Lyon INSERM CNRS, ENS de Lyon  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Boivin","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Qu\u00e9bec and Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"International Research Laboratory RESPIVIR France \u2010 Canada, Centre Hospitalier Universitaire de Qu\u00e9bec\u2010Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"Centre International de Recherche en Infectiologie Facult\u00e9 de M\u00e9decine RTH Laennec Universit\u00e9 Claude Bernard Lyon 1 Universit\u00e9 de Lyon INSERM CNRS, ENS de Lyon  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7559-9527","authenticated-orcid":false,"given":"Manuel","family":"Rosa\u2010Calatrava","sequence":"additional","affiliation":[{"name":"CIRI Centre International de Recherche en Infectiologie Team VirPath Inserm Universit\u00e9 Claude Bernard Lyon 1 CNRS, ENS de Lyon  Lyon France"},{"name":"Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Qu\u00e9bec and Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"International Research Laboratory RESPIVIR France \u2010 Canada, Centre Hospitalier Universitaire de Qu\u00e9bec\u2010Universit\u00e9 Laval  Qu\u00e9bec QC Canada"},{"name":"Centre International de Recherche en Infectiologie Facult\u00e9 de M\u00e9decine RTH Laennec Universit\u00e9 Claude Bernard Lyon 1 Universit\u00e9 de Lyon INSERM CNRS, ENS de Lyon  Lyon France"},{"name":"Virnext Facult\u00e9 de M\u00e9decine RTH Laennec Universit\u00e9 Claude Bernard Lyon 1  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.16.2.242\u2010264.2003"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.67.506"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu047"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2214\u2010109x(21)00218\u20107"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2023.05.003"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac172"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104261"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008883"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010023\u201036459\u20103"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.575977"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564\u2010024\u201001722\u2010w"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1912884"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1966.03100230063016"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101585"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120957"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120956"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a120955"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811980115"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.4.958"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168\u20101702(92)90049\u2010f"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.73.2.1374\u20101381.1999"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.655"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19522\u20100"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2316376121"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.2.1141\u20101148.2003"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.19.8922\u20108929.2000"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.24.11626\u201011635.2000"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.7.3188\u20103195.2000"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.20.10819\u201010828.2003"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.78.20.11198\u201011207.2004"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01373\u201015"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01196\u201016"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00189\u201017"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228572"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109744118"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011057"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010024\u201048059\u2010w"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010024\u201049757\u20101"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1445"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000066244.31769.83"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.12.002"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1086\/381184"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0b013e31822ea24f"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.09.046"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.07.031"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.6.1175\u20101182.1991"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1107"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454\u2010199608000\u201000003"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1086\/428092"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.022"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.018"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0b013e318199c3b1"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0b013e31823386f1"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.006"},{"key":"e_1_2_5_56_1","unstructured":"Eudract Number 2008\u2010002651\u201024 \u2010 Clinical Trial Results \u2010 EU Clinical Trials Register. [Internet] https:\/\/www.clinicaltrialsregister.eu\/ctr\u2010search\/trial\/2008\u2010002651\u201024\/results."},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac206"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023\u2010064748"},{"key":"e_1_2_5_59_1","unstructured":"Enrolling Studies [Internet]. \u201cSutherland Shire Clinical Research \u201d https:\/\/sutherlandshireclinicalresearch.com\/studies\/."},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/978\u20103\u2010642\u201038919\u20101_13"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020135"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890100403"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107586"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.60.1.90\u201096.1986"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010023\u201001408\u20105"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/978\u20103\u2010642\u201038919\u20101_4"},{"key":"e_1_2_5_67_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.75.10.4594\u20104603.2001"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.3.1089\u20101099.2002"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.015"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.03481\u201013"},{"key":"e_1_2_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.10.009"},{"key":"e_1_2_5_72_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012585"},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.11.006"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.07.068"},{"key":"e_1_2_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.053"},{"key":"e_1_2_5_76_1","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00618\u201014"},{"key":"e_1_2_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.04.022"},{"key":"e_1_2_5_78_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.79.21.13275\u201013284.2005"},{"key":"e_1_2_5_79_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1415"},{"key":"e_1_2_5_80_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.15.6821\u20106831.2000"},{"key":"e_1_2_5_81_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.75.21.10498\u201010504.2001"},{"key":"e_1_2_5_82_1","volume-title":"Chapter 2 \u2010 Biotechnology\u2010Based Therapeutics","author":"Abinaya R. V.","year":"2021"},{"key":"e_1_2_5_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.648"},{"key":"e_1_2_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264\u2010410x(91)90037\u20107"},{"key":"e_1_2_5_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.6.1219"},{"key":"e_1_2_5_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573\u2010024\u201001042\u2010y"},{"key":"e_1_2_5_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243"},{"key":"e_1_2_5_88_1","unstructured":"\u2018Safety Signal\u2019 in Moderna\u2019s RSV Vaccine Studies Halts Trials of Other Vaccines for Childhood Killer. [Internet] https:\/\/www.science.org\/content\/article\/safety\u2010signal\u2010moderna\u2010s\u2010rsv\u2010vaccine\u2010studies\u2010halts\u2010trials\u2010other\u2010vaccines\u2010childhood."},{"key":"e_1_2_5_89_1","unstructured":"2024 \u2010 Vaccines and Related Biological Products Advisory."},{"key":"e_1_2_5_90_1","unstructured":"Study of a Respiratory Syncytial Virus\/Human Metapneumovirus\/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older | Clinical Research Trial Listing [Internet] https:\/\/www.centerwatch.com\/clinical\u2010trials\/listings\/NCT06604767\/study\u2010of\u2010a\u2010respiratory\u2010syncytial\u2010virus\u2010human\u2010metapneumovirusparainfluenza\u2010virus\u2010type\u20103\u2010vaccine\u2010candidate\u2010in\u2010adults\u2010aged\u201060\u2010years\u2010and\u2010older\/study\u2010of\u2010a\u2010respiratory\u2010syncytial\u2010virus\u2010human\u2010metapneumovirusparainfluenza\u2010virus\u2010type\u20103\u2010vaccine\u2010candidate\u2010in\u2010adults\u2010aged\u201060\u2010years\u2010and\u2010older."},{"key":"e_1_2_5_91_1","unstructured":"Synagis | European Medicines Agency (EMA). [Internet].2009 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/synagis."},{"key":"e_1_2_5_92_1","unstructured":"Beyfortus | European Medicines Agency (EMA). [Internet].2022 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/beyfortus."},{"key":"e_1_2_5_93_1","unstructured":"U.S. FDA Approves Merck\u2019s ENFLONSIATM (Clesrovimab\u2010cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season \u2010 Merck.com [Internet] https:\/\/www.merck.com\/news\/u\u2010s\u2010fda\u2010approves\u2010mercks\u2010enflonsia\u2010clesrovimab\u2010cfor\u2010for\u2010prevention\u2010of\u2010respiratory\u2010syncytial\u2010virus\u2010rsv\u2010lower\u2010respiratory\u2010tract\u2010disease\u2010in\u2010infants\u2010born\u2010during\u2010or\u2010entering\u2010their\u2010fir\/."},{"key":"e_1_2_5_94_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02699\u201009"},{"key":"e_1_2_5_95_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2110275"},{"key":"e_1_2_5_96_1","unstructured":"PR. \u201cFDA Approves Beyfortustm(Nirsevimab\u2010alip) to Protect Infants Against RSV Disease [Internet] \u201d https:\/\/www.sanofi.com\/en\/media\u2010room\/press\u2010releases\/2023\/1vynd53k72.execute\u2010api.us\u2010east\u20101.amazonaws.com\/en\/media\u2010room\/press\u2010releases\/2023\/2023\u201007\u201017\u201017\u201000\u201000\u20102705911."},{"key":"e_1_2_5_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab191"},{"key":"e_1_2_5_98_1","unstructured":"Flumist\u2010Qlaiv\u2010Product\u2010Monograph\u2010En."},{"key":"e_1_2_5_99_1","unstructured":"Fluenz Tetra | European Medicines Agency (EMA). [Internet].2018 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/fluenz\u2010tetra."},{"key":"e_1_2_5_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541\u2010023\u201000700\u20103"},{"key":"e_1_2_5_101_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq0603"},{"key":"e_1_2_5_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010024\u201050133\u20102"},{"key":"e_1_2_5_103_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1655"},{"key":"e_1_2_5_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010024\u201002025\u20106"},{"key":"e_1_2_5_105_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13081498"}],"container-title":["Reviews in Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.70071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T04:41:28Z","timestamp":1764304888000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/rmv.70071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/rmv.70071"],"URL":"https:\/\/doi.org\/10.1002\/rmv.70071","archive":["Portico"],"relation":{},"ISSN":["1052-9276","1099-1654"],"issn-type":[{"value":"1052-9276","type":"print"},{"value":"1099-1654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"2025-05-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70071"}}